[HTML][HTML] Role of radiomics in the diagnosis and treatment of gastrointestinal cancer
Q Mao, MT Zhou, ZP Zhao, N Liu, L Yang… - World journal of …, 2022 - ncbi.nlm.nih.gov
Gastrointestinal cancer (GIC) has high morbidity and mortality as one of the main causes of
cancer death. Preoperative risk stratification is critical to guide patient management, but …
cancer death. Preoperative risk stratification is critical to guide patient management, but …
Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores
Background Several prognostic scores were designed in order to estimate the risk of
postoperative adverse events. None of them includes a component directly associated to the …
postoperative adverse events. None of them includes a component directly associated to the …
Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal …
M Watanabe, Y Baba, N Yoshida, T Ishimoto… - Annals of surgical …, 2014 - Springer
Background There is a consensus that neoadjuvant therapy is an essential component of
treatment for resectable advanced esophageal cancer. The aim of this study was to evaluate …
treatment for resectable advanced esophageal cancer. The aim of this study was to evaluate …
Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy
SE Heethuis, PSN van Rossum, IM Lips… - Radiotherapy and …, 2016 - Elsevier
Purpose To explore and evaluate the potential value of dynamic contrast-enhanced (DCE)
magnetic resonance imaging (MRI) for the prediction of pathologic response to neoadjuvant …
magnetic resonance imaging (MRI) for the prediction of pathologic response to neoadjuvant …
Validity of using pathological response as a surrogate for overall survival in neoadjuvant studies for esophageal cancer: a systematic review and meta-analysis
F Su, X Yang, J Yin, Y Shen, L Tan - Annals of Surgical Oncology, 2023 - Springer
Background Pathological response is a critical factor in predicting long-term survival of
patients with esophageal cancer after preoperative therapy. However, the validity of using …
patients with esophageal cancer after preoperative therapy. However, the validity of using …
Wee1 kinase inhibitor AZD1775 effectively sensitizes esophageal cancer to radiotherapy
Purpose: Esophageal cancer is a deadly malignancy with a 5-year survival rate of only 5%
to 20%, which has remained unchanged for decades. Esophageal cancer possesses a high …
to 20%, which has remained unchanged for decades. Esophageal cancer possesses a high …
[HTML][HTML] The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
GW van Pelt, JA Krol, IM Lips, FP Peters… - Clinical and translational …, 2020 - Elsevier
Background and purpose With currently available techniques, the prediction of pathologic
complete response after neoadjuvant chemoradiotherapy is insufficient. The tumor-stroma …
complete response after neoadjuvant chemoradiotherapy is insufficient. The tumor-stroma …
The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal …
X Wang, W Yang, Q Zhou, H Luo, W Chen… - European Journal of …, 2022 - Springer
Purpose Accurate assessment of residual disease of tumor and lymph nodes after
neoadjuvant immunochemotherapy is crucial in the active surveillance for patients with …
neoadjuvant immunochemotherapy is crucial in the active surveillance for patients with …
[HTML][HTML] Impact of pathological complete response following neoadjuvant chemoradiotherapy in esophageal cancer
T Soror, G Kho, KL Zhao, M Ismail… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Background Neoadjuvant radiochemotherapy (nRCT) followed by surgery has become the
gold standard treatment in patients with locally advanced esophageal cancer. The …
gold standard treatment in patients with locally advanced esophageal cancer. The …
Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer?
Objective: The aim of this study is to assess CT-PET and endoscopic assessment
postneoadjuvant chemoradiotherapy (nCRT) in predicting complete pathologic response …
postneoadjuvant chemoradiotherapy (nCRT) in predicting complete pathologic response …